Search

everythinglearnresearchcommunity

for

Search:↓

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

A patient with a larger than usual genetic mutation had a broader range of symptoms for a muscle disease.

Metformin taken during pregnancy increases SHBG in newborns but doesn't change other hormone levels in mothers or babies.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Early hair loss may indicate prostate issues.

Lovastatin doesn't improve lower urinary tract symptoms treatment.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Obesity increases the risk of skin infections, inflammatory conditions, and melanoma, but not basal cell carcinoma.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Testosterone replacement therapy should be used for men with low testosterone levels and symptoms of hypogonadism, after careful diagnosis and considering individual needs.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Korean patients with PCOS often have skin problems like acne and excess hair, with different symptoms based on their specific PCOS type.

The Chinese version of the PCOS quality of life questionnaire is reliable and valid for Chinese-speaking women with PCOS.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Finasteride 5-mg oral disintegrating tablets and standard tablets are bioequivalent in healthy adult male Han Chinese volunteers.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.